NCT01313364View on ClinicalTrials.gov

A Safety Study in Healthy Volunteers of the Single-Use Autoinjector Containing Placebo of BG9418 Interferon Beta-1a With a 25-Gauge × 1-Inch Needle

PHASE1TerminatedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Healthy
Interventions
DEVICE

"25G x 1 Needle Autoinjector"

All subjects will self-administer 4 IM injections using single-use autoinjectors.

Trial Locations (1)

Unknown

Research Site, Toronto

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY

NCT01313364 - A Safety Study in Healthy Volunteers of the Single-Use Autoinjector Containing Placebo of BG9418 Interferon Beta-1a With a 25-Gauge × 1-Inch Needle | Biotech Hunter | Biotech Hunter